Skip to main content

Advertisement

SpringerLink
Log in

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Beach TG, White CL, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH, The Arizona Parkinson’s Disease Consortium (2008) Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol. doi:10.1007/s00401-008-0450-7 (in press)

  2. Duda JE, Noorigian JV, Petrovitch H, White LR, Ross GW (2007) Pattern of Lewy pathology progression suggested by Braak staging system is supported by analysis of a population-based cohort of patients. The Movement Disorder Society’s 11th International Congress of Parkinson’s Disease and Movement Disorders late breaking abstracts, A3

  3. Greffard S, Verny M, Bonnet AM, Beinis JY, Gallinari C, Meaume S, Piette F, Hauw JJ, Duyckaerts C (2006) Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol 63:584–588. doi:10.1001/archneur.63.4.584

    Article  PubMed  Google Scholar 

  4. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861–870. doi:10.1093/brain/awf080

    Article  PubMed  Google Scholar 

  5. Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671. doi:10.1093/brain/awh303

    Article  PubMed  Google Scholar 

  6. Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399–407. doi:10.1007/s00401-008-0346-6

    Article  PubMed  Google Scholar 

  7. Uchikado H, DelleDonne A, Ahmed Z, Dickson DW (2006) Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol 65:387–395. doi:10.1097/01.jnen.0000218449.17073.43

    Article  PubMed  CAS  Google Scholar 

  8. Zaccai J, Brayne C, McKeith I, Matthews F, Ince P (2008) Patterns and stages of α-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042–1048. doi:10.1212/01.wnl.0000306697.48738.b6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK

    Laura Parkkinen, Janice L. Holton, Andrew J. Lees & Tamas Revesz

  2. Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK

    Laura Silveira-Moriyama, Janice L. Holton & Andrew J. Lees

Authors
  1. Laura Parkkinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Silveira-Moriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janice L. Holton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andrew J. Lees
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tamas Revesz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tamas Revesz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parkkinen, L., Silveira-Moriyama, L., Holton, J.L. et al. Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”. Acta Neuropathol 117, 213–214 (2009). https://doi.org/10.1007/s00401-008-0462-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-008-0462-3

Keywords

Search

Navigation